Project Details
Description
Tolerogenic Efficacy and Safety of Apoptotic Donor Leukocytes and Transient Immunosuppression with ASKP1240, Rapamycin, Etanercept, and Tocilizumab in a Preclinical Islet Allotransplant Model in Cynomolgus Monkeys
| Status | Finished |
|---|---|
| Effective start/end date | 10/1/19 → 1/21/23 |
Funding
- DIABETES-FREE, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.